| 產(chǎn)品編號(hào) | bs-24825P |
| 英文名稱(chēng) | SARS-CoV-2 (2019-nCoV) Spike RBD (K417N) Mutated Peptide |
| 中文名稱(chēng) | SARS冠狀病毒2 Spike蛋白R(shí)BD(K417N)突變多肽 |
| 別 名 | SARS-CoV-2 spike protein; 2019-nCOV Spike protein; Spike glycoprotein; Spike protein S1; Spike protein RBD; Surface glycoprotein; SPIKE_SARS2; 2019-nCOV Spike protein (K417N). SARS冠狀病毒2 Spike突變蛋白R(shí)BD(K417N)多肽 |
| 理論分子量 | kDa |
| 檢測(cè)分子量 | |
| 性 狀 | Lyophilized |
| 純化方法 | HPLC |
| 活性 | Not tested |
| 保存條件 | Shipped at 4℃. Stored at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensin-converting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
